Radiotherapy Physics
91 – 100 of 158
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
The role of surface-guided radiation therapy for improving patient safety
Al-Hallaq, Hania ; Batista, Vania ; Kügele, Malin LU
; Ford, Eric
; Viscariello, Natalie
and Meyer, Juergen
(2021)
In Radiotherapy and Oncology
163.
p.229-236
- Contribution to journal › Article
-
Mark
A deeply supervised convolutional neural network ensemble for multilabel segmentation of pelvic OARs
Lempart, Michael LU ; Nilsson, Martin LU ; Scherman, Jonas ; Nilsson, Mikael LU
; Jamtheim Gustafsson, Christian
LU
; Munck Af Rosenschöld, Per
LU
and Olsson, Lars E
LU
(2021)
European Society Radiation Oncology 2021
In Radiotherapy and Oncology
161(Suppl 1).
p.1417-1418
- Contribution to journal › Published meeting abstract
-
Mark
Intracavitary Electron FLASH Radiotherapy in a Canine Cancer Patient With Oral Malignant Melanoma
Konradsson, E LU ; Arendt, M L ; Jensen, K Bastholm ; Thomasson, H ; Børresen, B ; Petersson, K LU and Ceberg, C LU
(2021)
In International Journal of Radiation Oncology, Biology, Physics
111(3S).
p.31-31
- Contribution to journal › Article
-
Mark
PO-1767 Surface guided FLASH radiotherapy
Mannerberg, Annika LU ; Konradsson, Elise LU ; Kügele, Malin LU
; Edvardsson, Anneli
LU
; Ceberg, Crister
LU
; Thomasson, H
; Arendt, M. L.
; Bastholm Jensen, K
and Ceberg, Sofie
LU
(2021)
European Society Radiation Oncology 2021
In Radiotherapy and Oncology
161(Suppl 1).
p.1494-1496
- Contribution to journal › Published meeting abstract
-
Mark
ARTSCAN III : A randomized phase III study comparing chemoradiotherapy with cisplatin versus cetuximab in patients with locoregionally advanced head and neck squamous cell cancer
- Contribution to journal › Article
-
Mark
Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC) : patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial
Fransson, Per ; Nilsson, Per LU
; Gunnlaugsson, Adalsteinn
LU
; Beckman, Lars
; Tavelin, Björn
; Norman, David
; Thellenberg-Karlsson, Camilla
; Hoyer, Morten
; Lagerlund, Magnus
and Kindblom, Jon
, et al.
(2021)
In The Lancet Oncology
22(2).
p.235-245
- Contribution to journal › Article
- 2020
-
Mark
Palliative short-course hypofractionated radiotherapy followed by chemotherapy in esophageal adenocarcinoma : the phase II PALAESTRA trial
Borg, David LU ; Sundberg, Jan ; Brun, Eva LU ; Kjellén, Elisabeth LU ; Petersson, Kristoffer LU ; Hermansson, Michael LU ; Johansson, Jan LU
; Eberhard, Jakob
LU
and Johnsson, Anders
LU
(2020)
In Acta Oncologica
59(2).
p.212-218
- Contribution to journal › Article
-
Mark
Growth pattern of experimental glioblastoma
Ahlstedt, Jonatan LU
; Förnvik, Karolina
LU
; Helms, Gunther
LU
; Salford, Leif G
LU
; Ceberg, Crister
LU
; Skagerberg, Gunnar
LU
and Nittby, Henrietta
LU
(2020)
In Histology and Histopathology
35(8).
p.871-886
- Contribution to journal › Article
-
Mark
Ultra-High Dose Rate (FLASH) Radiotherapy : Silver Bullet or Fool's Gold?
- Contribution to journal › Scientific review
-
Mark
APM Task Group 329 : Reference dose specification for dose calculations: Dose-to-water or dose-to-muscle?
Kry, Stephen F. ; Feygelman, Vladimir ; Balter, Peter ; Knöös, Tommy LU
; Charlie Ma, C. M.
; Snyder, Michael
; Tonner, Brian
and Vassiliev, Oleg N.
(2020)
In Medical Physics
47(3).
p.52-64
- Contribution to journal › Article